DRL's net up 14% at Rs 626 crore; Russia a drag
The company had posted a net profit of Rs 550.39 crore for the corresponding quarter of the previous fiscal, Dr Reddy's Laboratories said in a BSE filing.
Jul 30, 2015, 14:45 PM IST
CAG blames I-T Dept for Rs 1348 cr tax loss in pharma sector
Coming down heavily on the I-T Department, CAG has said non-compliance of procedures for giving incentives to pharmaceutical firms, including Ranbaxy, Dr Reddy's and Piramal, resulted Rs 1,348.44 crore loss to the exchequer.
Mar 20, 2015, 19:28 PM IST
Dr Reddy's Q3 Net declines 7.09% to Rs 574.53 crore
The company had posted a consolidated net profit of Rs 618.42 crore in the October-December period of the previous financial year, it said in a BSE filing.
Jan 29, 2015, 14:04 PM IST
Dr Reddy's launches generic anti-viral tablets in US market
The tablets are generic version of Roche's Valcyte tablets, it added.
Dec 16, 2014, 13:42 PM IST
